ISSN : 2347-5447
Nanotechnology has been more prevalent in our daily lives in recent years. Through an integrated approach, this groundbreaking technology has been implemented in a variety of industries. A growing number of applications and goods containing nanoparticles, or at least claiming to be based on nanotechnology, are now accessible. This occurs in pharmaceutical research as well. Nanotechnology is now being used in the development of novel medications, and it has been designated as a Key Enabling Technology in the European Union (EU), capable of bringing new and creative medical solutions to address unmet medical needs.
British Biomedical Bulletin received 971 citations as per Google Scholar report